SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.257
EU - Europa 4.427
AS - Asia 4.247
SA - Sud America 69
OC - Oceania 35
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.146
CN - Cina 1.736
SG - Singapore 1.357
IT - Italia 1.142
DE - Germania 754
UA - Ucraina 612
TR - Turchia 487
GB - Regno Unito 460
FI - Finlandia 378
ID - Indonesia 296
PL - Polonia 295
SE - Svezia 279
FR - Francia 137
CA - Canada 106
BE - Belgio 93
VN - Vietnam 80
HK - Hong Kong 69
IN - India 64
NL - Olanda 57
BR - Brasile 48
LT - Lituania 38
CZ - Repubblica Ceca 35
AU - Australia 32
KR - Corea 29
JP - Giappone 24
RU - Federazione Russa 23
EG - Egitto 22
ES - Italia 19
IR - Iran 18
CH - Svizzera 15
IE - Irlanda 13
MY - Malesia 13
PK - Pakistan 12
DK - Danimarca 11
AT - Austria 10
TH - Thailandia 10
TW - Taiwan 10
RO - Romania 8
IQ - Iraq 7
CO - Colombia 6
PT - Portogallo 6
CL - Cile 5
CY - Cipro 5
MK - Macedonia 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
MX - Messico 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
AR - Argentina 3
BG - Bulgaria 3
HR - Croazia 3
KE - Kenya 3
LI - Liechtenstein 3
NZ - Nuova Zelanda 3
PH - Filippine 3
VE - Venezuela 3
ZA - Sudafrica 3
AL - Albania 2
BD - Bangladesh 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
GR - Grecia 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
PS - Palestinian Territory 2
SI - Slovenia 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
EC - Ecuador 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
TM - Turkmenistan 1
Totale 26.072
Salva come PNG Salva come JPEG
Città #
Fairfield 2.306
Woodbridge 1.817
Ashburn 1.317
Santa Clara 1.287
Houston 1.176
Singapore 1.104
Chandler 1.034
Seattle 944
Wilmington 851
Ann Arbor 809
Cambridge 767
Jacksonville 758
Izmir 339
Beijing 327
Princeton 325
Warsaw 285
Jakarta 275
Nanjing 270
New York 261
Shanghai 260
Munich 247
Helsinki 231
Ferrara 228
San Diego 206
Milan 190
Boardman 134
Los Angeles 115
London 104
Brussels 91
Bremen 80
Shenyang 74
Bologna 73
Nanchang 72
Redwood City 64
Falls Church 63
Frankfurt am Main 53
Jiaxing 52
Tianjin 52
Toronto 52
Washington 50
Hong Kong 49
Mountain View 44
Changsha 41
Hebei 40
Dong Ket 39
Addison 34
San Mateo 34
Ottawa 33
Norwalk 32
Jinan 28
Lappeenranta 28
Chicago 27
Rome 25
Brno 24
Des Moines 24
Kunming 23
Orange 22
Augusta 21
Guangzhou 21
Ningbo 20
Redmond 20
Zhengzhou 19
Falkenstein 16
Melbourne 16
Rimini 16
Tappahannock 16
Auburn Hills 15
Dearborn 15
Mumbai 15
Taizhou 13
Tokyo 13
Hangzhou 12
Leawood 12
Monmouth Junction 12
Napoli 12
Amsterdam 11
Dublin 10
Hounslow 10
Indiana 10
Kilburn 10
São Paulo 10
Lugo 9
Bangkok 8
Chennai 8
Ferrara di Monte Baldo 8
Florence 8
Lanzhou 8
Montreal 8
Parma 8
Phoenix 8
Treviso 8
Ardabil 7
Arezzo 7
Cairo 7
Changchun 7
Naples 7
Nuremberg 7
Olomouc 7
Padova 7
Atlanta 6
Totale 19.778
Salva come PNG Salva come JPEG
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 271
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 267
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 198
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 186
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 183
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 179
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 170
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 169
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 168
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 168
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 154
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 152
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 151
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 151
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 147
Poor response to clopidogrel: current and future options for its management 147
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 146
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 145
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 143
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 142
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 142
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 142
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 141
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 141
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 141
Notch Signaling Regulates Immune Responses in Atherosclerosis 139
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 138
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 138
Mechanistic role of mPTP in ischemia-reperfusion injury 136
Fractional flow reserve: Current applications and overview of the available data 135
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 135
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 133
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 132
Reperfusion Damage - A Story of Success, Failure, and Hope 132
Can we improve myocardial protection during ischaemic injury? 132
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial 131
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention 130
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 129
The Mitochondrial Permeability Transition Pore 129
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 129
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 128
Characterization of Dermal Stem Cells of Diabetic Patients 128
The in vitro effects of verbascoside on human platelet aggregation 127
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 127
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 127
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 125
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 124
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 123
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 122
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 122
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 122
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 121
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry 121
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 120
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 120
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 120
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 120
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 119
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 119
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 119
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 119
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 118
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 118
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 117
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 116
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 115
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 115
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 115
A Strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. 114
Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions 114
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 114
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 114
Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the registro regionale angioplastiche Emilia-Romagna registry) 113
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 112
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 112
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 112
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study 111
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 111
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 111
Fractional flow reserve implementation in daily clinical practice: A European survey 111
BRS implantation in long lesions requiring device overlapping: Myth or reality? 111
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. 110
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 110
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 110
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 110
Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes 109
Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis 109
Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry 109
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 109
Impact of culprit plaque and atherothrombotic components on incomplete stent apposition in patients with ST-elevation myocardial infarction treated with Everolimus-eluting stents-an OCTAVIA Substudy 107
A Prospective Evaluation of a Standardized Strategy for the Use of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in ST-Segment Elevation Myocardial Infarction: Rationale and Design of the BVS STEMI STRATEGY-IT Study 106
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 105
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. 104
New and old strategies to afford the liberal use of drug-eluting stents in real-life scenarios 104
Incidence and outcome of high on-treatment platelet reactivity in patients with non-st elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the VIP [verifynow and inhibition of platelet reactivity] study) 104
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 103
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 102
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 102
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 101
Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results 101
Totale 13.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.343
Totale 179.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.170 0 0 0 0 0 0 473 474 433 435 225 130
2020/20213.841 198 262 194 489 231 300 166 498 174 541 536 252
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/20254.995 313 330 920 586 1.425 1.211 210 0 0 0 0 0
Totale 27.071